Venture Growth in Healthcare - Series A/B Investment Strategies

​Following our last breakfast on the topic of early stage investing, in May we'll move up the funding cycle to Series A and B - the venture growth phase where capital requirements rise and investment risks shift.

​APAC's Series A activity is picking up alongside global early-stage momentum, but the bridge to Series B still remains thinner than in the US or Europe. In this discussion, we will cover:

• ​What changes at A/ B - diligence, valuation, and conviction shifts

• ​What's getting funded at A/ B, what isn't, and where the opportunities are for APAC investors

• ​Syndication, deal structuring, and follow-on financing

​A closed-door conversation for investors exploring or deploying in health/ life sciences.

​Attendance is subject to approval.